{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:00:51Z","timestamp":1780329651844,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection. Toll-like receptor 4 plays a central role in pathogen recognition and inflammatory signalling and has been considered a key driver of sepsis pathophysiology. Pharmacological inhibition of this receptor showed beneficial effects in experimental models but failed in clinical trials. We therefore aimed to quantify in vivo activation of Toll-like receptor 4 in patients with sepsis and to determine its association with 30-day survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood mononuclear cells were obtained from 100 patients with sepsis enrolled in the SepsisDataNet.NRW cohort. Samples were collected on day 1 (within 36\u00a0h after diagnosis) and day 4. Activation of TLR4 was quantified by measuring receptor phosphorylation using a validated proximity ligation assay. Survival analyses were performed using Kaplan-Meier curves and Cox proportional hazards regression models to assess the association between receptor activation and 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall activation of TLR4 was low, with median values below one signal per cell at both day 1 and day 4. Despite the generally low levels, a subgroup of patients showed increased receptor activation. Higher activation was associated with significantly reduced 30-day survival. Patients with elevated activation had a higher risk of death both at day 1 (HR 2.03, 95% CI 1.01\u20134.07,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048) and day 4 (HR 2.77, 95% CI 1.14\u20136.73,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025). This association remained significant after adjustment for SOFA score at admission, age, infection focus and sex in multivariable Cox regression analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In vivo activation of TLR4 is not uniformly present in patients with sepsis but occurs only in a subset of individuals. In those patients, increased activation is strongly associated with mortality. These findings suggest the presence of a distinct high-risk sepsis endotype characterized by enhanced receptor activation. This may help explain the failure of previous clinical trials of TLR4 inhibitors and supports the concept of biomarker-guided precision medicine approaches in sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register (DRKS), DRKS00018871, retrospectively registered on 14 November 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06115-5","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:43:58Z","timestamp":1780134238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphorylated toll-like receptor 4 defines a high-risk sepsis endotype"],"prefix":"10.1186","volume":"30","author":[{"given":"Madita","family":"M\u00fchlhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Witowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Unterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"von Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Ziehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Thon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Palmowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Westhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Felix","family":"Ehrentraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Bracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eisenacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Ellger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schwier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Henzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Putensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich Hermann","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Anft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Babel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmuth","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rahmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Adamzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Koos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SepsisDataNet.NRW research group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"5","key":"6115_CR1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/a-1783-7212","volume":"57","author":"L Palmowski","year":"2022","unstructured":"Palmowski L, Adamzik M, Rahmel T. [Not Available]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2022;57(5):360\u201370.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"10219","key":"6115_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"8","key":"6115_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"6115_CR4","doi-asserted-by":"publisher","first-page":"628302","DOI":"10.3389\/fmed.2021.628302","volume":"8","author":"D Jarczak","year":"2021","unstructured":"Jarczak D, Kluge S, Nierhaus A. Sepsis-Pathophysiology and Therapeutic Concepts. Front Med (Lausanne). 2021;8:628302.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"6115_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12519-023-00689-8","volume":"19","author":"W Wang","year":"2023","unstructured":"Wang W, Liu CF. Sepsis heterogeneity. World J Pediatr. 2023;19(10):919\u201327.","journal-title":"World J Pediatr"},{"issue":"7","key":"6115_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood-2008-07-019307","volume":"113","author":"BA Beutler","year":"2009","unstructured":"Beutler BA. TLRs and innate immunity. Blood. 2009;113(7):1399\u2013407.","journal-title":"Blood"},{"issue":"5","key":"6115_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cytogfr.2014.06.002","volume":"25","author":"S Chattopadhyay","year":"2014","unstructured":"Chattopadhyay S, Sen GC. Tyrosine phosphorylation in Toll-like receptor signaling. Cytokine Growth Factor Rev. 2014;25(5):533\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"6115_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu YC, Yeh WC, Ohashi PS. LPS\/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145\u201351.","journal-title":"Cytokine"},{"issue":"11","key":"6115_CR9","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.4049\/jimmunol.1100967","volume":"187","author":"MJ Smolinska","year":"2011","unstructured":"Smolinska MJ, Page TH, Urbaniak AM, Mutch BE, Horwood NJ. Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1. J Immunol. 2011;187(11):6043\u201351.","journal-title":"J Immunol"},{"key":"6115_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cells11193020","volume":"11","author":"P Thon","year":"2022","unstructured":"Thon P, Rump K, Knorr A, Dyck B, Ziehe D, Unterberg M, et al. The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis. Cells. 2022;11:19.","journal-title":"Cells"},{"issue":"10","key":"6115_CR11","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1161\/ATVBAHA.107.146100","volume":"27","author":"S Ehrentraut","year":"2007","unstructured":"Ehrentraut S, Frede S, Stapel H, Mengden T, Grohe C, Fandrey J, et al. Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility. Arterioscler Thromb Vasc Biol. 2007;27(10):2170\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"6115_CR12","doi-asserted-by":"publisher","first-page":"e44531","DOI":"10.1371\/journal.pone.0044531","volume":"7","author":"SF Ehrentraut","year":"2012","unstructured":"Ehrentraut SF, Dorr A, Ehrentraut H, Lohner R, Lee SH, Hoeft A, et al. Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors. PLoS ONE. 2012;7(9):e44531.","journal-title":"PLoS ONE"},{"issue":"15","key":"6115_CR13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/ars.2021.0005","volume":"35","author":"F Chen","year":"2021","unstructured":"Chen F, Zou L, Williams B, Chao W. Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials. Antioxid Redox Signal. 2021;35(15):1324\u201339.","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"6115_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/eurjhf\/hfr035","volume":"13","author":"H Ehrentraut","year":"2011","unstructured":"Ehrentraut H, Weber C, Ehrentraut S, Schwederski M, Boehm O, Knuefermann P, et al. The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy. Eur J Heart Fail. 2011;13(6):602\u201310.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"6115_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/SHK.0b013e318235805f","volume":"36","author":"S Ehrentraut","year":"2011","unstructured":"Ehrentraut S, Lohner R, Schwederski M, Ehrentraut H, Boehm O, Noga S, et al. In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia. Shock. 2011;36(6):613\u201320.","journal-title":"Shock"},{"issue":"11","key":"6115_CR16","doi-asserted-by":"publisher","first-page":"e0142921","DOI":"10.1371\/journal.pone.0142921","volume":"10","author":"H Ehrentraut","year":"2015","unstructured":"Ehrentraut H, Felix Ehrentraut S, Boehm O, El Aissati S, Foltz F, Goelz L, et al. Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation. PLoS ONE. 2015;10(11):e0142921.","journal-title":"PLoS ONE"},{"issue":"6","key":"6115_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/ALN.0000000000000337","volume":"121","author":"M Zhang","year":"2014","unstructured":"Zhang M, Zou L, Feng Y, Chen YJ, Zhou Q, Ichinose F, et al. Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis. Anesthesiology. 2014;121(6):1270\u201380.","journal-title":"Anesthesiology"},{"issue":"11","key":"6115_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jama.2013.2194","volume":"309","author":"SM Opal","year":"2013","unstructured":"Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154\u201362.","journal-title":"JAMA"},{"issue":"9","key":"6115_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13(9):679\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6115_CR20","first-page":"49","volume":"27","author":"P Chansrichavala","year":"2009","unstructured":"Chansrichavala P, Chantharaksri U, Sritara P, Chaiyaroj SC. Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol. 2009;27(1):49\u201357.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"5","key":"6115_CR21","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41366-021-00768-8","volume":"45","author":"AM Cuevas","year":"2021","unstructured":"Cuevas AM, Clark JM, Potter JJ. Increased TLR\/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity? Int J Obes (Lond). 2021;45(5):1152\u20134.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"6115_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348.","journal-title":"Int Immunol"},{"issue":"5","key":"6115_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357.","journal-title":"Nat Immunol"},{"key":"6115_CR24","doi-asserted-by":"crossref","unstructured":"Sharma J, Boyd T, Alvarado C, Gunn E, Adams J, Ness T et al. Reporter Cell Assessment of TLR4-Induced NF-kappaB Responses to Cell-Free Hemoglobin and the Influence of Biliverdin. Biomedicines. 2019;7(2):41 .","DOI":"10.3390\/biomedicines7020041"},{"issue":"4","key":"6115_CR25","first-page":"3376","volume":"15","author":"S Zhou","year":"2018","unstructured":"Zhou S, Wang G, Zhang W. Effect of TLR4\/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response. Exp Ther Med. 2018;15(4):3376\u201384.","journal-title":"Exp Ther Med"},{"issue":"1","key":"6115_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cvr\/cvaa070","volume":"117","author":"EV Dolmatova","year":"2021","unstructured":"Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021;117(1):60\u201373.","journal-title":"Cardiovasc Res"},{"key":"6115_CR27","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3389\/fimmu.2020.01683","volume":"11","author":"BK Dhillon","year":"2020","unstructured":"Dhillon BK, Smith M, Baghela A, Lee AHY, Hancock REW. Systems Biology Approaches to Understanding the Human Immune System. Front Immunol. 2020;11:1683.","journal-title":"Front Immunol"},{"issue":"1","key":"6115_CR28","doi-asserted-by":"publisher","first-page":"L16","DOI":"10.1152\/ajplung.00044.2008","volume":"295","author":"RE Gerszten","year":"2008","unstructured":"Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG, et al. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L16\u201322.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"6115_CR29","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1016\/j.cell.2025.03.013","volume":"188","author":"E Malmstrom","year":"2025","unstructured":"Malmstrom E, Malmstrom L, Hauri S, Mohanty T, Scott A, Karlsson C, et al. Human proteome distribution atlas for tissue-specific plasma proteome dynamics. Cell. 2025;188(10):2810\u201322. e16.","journal-title":"Cell"},{"issue":"8","key":"6115_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/CS20220777","volume":"137","author":"W Chancharoenthana","year":"2023","unstructured":"Chancharoenthana W, Kamolratanakul S, Schultz MJ, Leelahavanichkul A. The leaky gut and the gut microbiome in sepsis - targets in research and treatment. Clin Sci (Lond). 2023;137(8):645\u201362.","journal-title":"Clin Sci (Lond)"},{"issue":"22","key":"6115_CR31","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.1074\/jbc.M606781200","volume":"282","author":"AE Medvedev","year":"2007","unstructured":"Medvedev AE, Piao W, Shoenfelt J, Rhee SH, Chen H, Basu S, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem. 2007;282(22):16042\u201353.","journal-title":"J Biol Chem"},{"issue":"10","key":"6115_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009;30(10):475\u201387.","journal-title":"Trends Immunol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06115-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:02:34Z","timestamp":1780326154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6115"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06115-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SepsisDataNet.NRW study was approved by the Ethics Committee of the Medical Faculty of Ruhr University Bochum (approval numbers 18-6606 BR for recruitment and 22-7477 for analysis) and by the responsible ethics committees at each participating recruitment center. Written informed consent was obtained from all participants. If participants were unable to provide consent at inclusion, an independent physician was consulted and consent was obtained from participants after recovery in accordance with the ethics approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}